Overview
Yumi Hironaka practices practicing medicine in Tokyo, Japan.
Her clinical expertise encompasses Acute Promyelocytic Leukemia, Essential Thrombocythemia, Polycythemia Vera, and Myeloproliferative Neoplasms (MPN).
She is actively involved in clinical research, co-authoring 13 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yumi Hironaka
Is Yumi Hironaka a top-rated expert for Acute Promyelocytic Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Yumi Hironaka is classified as an Experienced expert for Acute Promyelocytic Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yumi Hironaka participate in research or clinical trials?
Yes. Yumi Hironaka has published 13 articles and abstracts on conditions like Acute Promyelocytic Leukemia. You can view a list of Yumi Hironaka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Erythroid Leukemia (AEL)Ms. Hironaka isExperienced. Learn about Acute Erythroid Leukemia (AEL).
- Acute Myeloid Leukemia (AML)Ms. Hironaka isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaMs. Hironaka isExperienced. Learn about Acute Promyelocytic Leukemia.
- Blood ClotsMs. Hironaka isExperienced. Learn about Blood Clots.
- Essential ThrombocythemiaMs. Hironaka isExperienced. Learn about Essential Thrombocythemia.
- LeukemiaMs. Hironaka isExperienced. Learn about Leukemia.
- MyelofibrosisMs. Hironaka isExperienced. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)Ms. Hironaka isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Polycythemia VeraMs. Hironaka isExperienced. Learn about Polycythemia Vera.